1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow AVE1625: new trials by email Literature Review of AVE1625 trials Research Report on AVE1625
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Activity of AVE1625 in Mild to Moderate Alzheimer's Patients. AVE1625 - Alzheimer Disease | Phase 1 / Phase 2 | Completed | Sanofi | 162 | 2006-09-01 | 2008-12-19 |
Sanofi (1)
France (1) · Italy (1) · Netherlands (1) · Sweden (1) · United States (1)